Home » Blog » Archive for category "Watchlist"

Archive for the ‘Watchlist’ Category:


Watchlist for 1/17/12

QCOR
Questcor Pharmaceuticals, Inc. Short squeeze caused by Streetsweeper during the close, Long biased on the bounce during the morning considering it held nicely through support at the close.

ACAS
American Capital Ltd. Buying the confirmed breakout if it hits 7.45.

WLK
Westlake Chemical Corporation. Watching it closely as it reaches the $55 key level. A possible short into the afternoon fade considering it was downgraded by rating giant Fitch after market hours closed on Friday. A rejection of 1.03 billion to buy rival Georgia Gulf was released on Monday, which could mean no continuing buying. Waiting for a pullback.

MY
China Ming Yang Wind Power Group Ltd. Very nice gradual increase in volume throughout last week. Buying strength building up as it takes out key monthly resistance. Looking to scalp it on the morning from momentum buying when it takes out 2.60.

IRE
Governor & Co. of the Bank of Ireland. Very nice run up in volume in breakout territory. Watching closely for that pop at 5.10

IDIX
Idenix Pharmaceuticals Inc. The gap up and the snowballing squeeze. Watching for the short biased area at $15. I bet market makers are all over this one.

STEV:BB
Stevia Corp. Watching closely for a pullback and the bounce on this pump.

Potential plays for tomorrow:
ACHN
ZLTQ
MBLX
TSLA
SFLY
SAGE



Watchlist 12/22

CIE
Cobalt International Energy, Inc. (CIE) was a major play in my watchlist today, even though I got too impatient and took my profits quickly. The news have been overwhelming from big names such as Forbes, which potentially adds more liquidity to a stock that has broken it’s previous high. Hopefully it cracks 16 for another potential long.

PCYC
Pharmacyclics Inc. (PCYC) was on my watchlist yesterday but didn’t end up playing it. Suggested by InvestorsLive on a possible short opportunity in the $16 range for the market open.

BTX
BioTime, Inc. (BTX) showed great buying momentum today. The hammer-like candlestick means it closed near it’s highs, but also a weakness from the previous momentum. Seeing how it tests the $16 range. Possible afternoon fade.

HERO
Cracked the previous high. Potential long, aiming for .50 cents if it decides to test resistance again at $4.85.

EP
Lot’s of hedge funds are bullish on this stock. Might ride the way up when it pops resistance or on the way down if it fails the third test. Probably won’t play it.



Watchlist for today

A lot has happened these past few weeks. I continue to plan ahead and prepare for the months to come. I recently just started watching the DVD collection by Timothy Sykes (one of my favorite traders) and there has been so much learning going on. Today I managed to finish the Pennystocking DVD while jotting down a couple pages of notes. Tonight I spent some time creating a watchlist for tomorrow. There were a lot of technical stocks I didn’t mention, but I don’t want to go hardcore just yet. I just want but to scratch the surface and get a feel for it.

ISTA
This company has been experiencing a hostile bid from Valeant Pharmaceuticals (VRX) for a while now, resulting in high volatility and liquidity. However, the company announced a $314 million rejection that still remains after the market closed on Friday. The offer will only remain in effect until Jan. 31st as stated by Valeant. A shareholder meeting taking place Jan. 12 and ISTA’s expectations of being a $1 billion pharmaceutical specialty firm could potentially keep stockholders in their positions. The increasingly message board and social media hype has made this stock one of the most to look for once the market opens on Monday. A potential buy if it cracks the 8 dollar resistance level, at which can surge much higher. A potential short early in the market open if it experiences a morning panic due to the acquisition rejection that has left mixed feelings during the weekend. Watching closely for consolidation and afternoon fade.

CIE
Shares up 23% after extending a rig lease to Diamond Offshore (DO). A potential long oil play after a breakout at 11.50. Commodity futures down 1% for Monday, which doesn’t concern me.

GRO
A technical breakout can be around the corner if the stock breaks the 1.50 resistance. Not very volatile in price, therefore not looking for much potential return. Almost no message board hype. Scalping at best.

RRR
Gradual stair-stepper pattern and potential long as it continues to make higher highs. Gapped-up ridiculously with a surge in volume last trading day with A LOT of news coverage.



Stocks to Watch

We are going to start things off with Eastman Kodak EK who is contemplating on whether to sell their online photo-sharing business known as Kodak Gallery in efforts to evade potential bankruptcy. It has been noted that private-equity firms and retailers are looking into buying Kodak Gallery. The sale could potentially net “hundreds of millions of dollars” according to anonymous sources. Shares were up to 5.9% to $1.26.

Next up is Nike

NKE, who has just raised their dividend payout to 36 cents a share from 31 cents. The new dividend will be payable Jan. 3 to stockholders. This is the 10th year in a row in which Nike has increased its dividend. Shares were at a flat of $91.90.

Moving on, Mentor Graphics Corp.’s MENT fiscal third-quarter profit rose to a high of 58%. The chip-design software company experienced a major increase in not only revenue, but bookings as well. During this period, shares rose 3.4% to $11.80.

Continue reading “Stocks to Watch” »



5 Stocks Hedge Funds Like

There are many stocks in which hedge funds invest in, here are 5 that will give you a better overlook as to what top hedge funds are thinking as of now. In today’s time, hedge funds like to keep their hands on technology stocks as quite a few are performing extremely well and money is always to be made. When looking at these 5 stocks, you will be able to see they are not volatile stocks whatsoever, they might have a small drop but are always back up; profits are always there.

We have Microsoft MSFT, Apple AAPL, and Google GOOG as the top three most popular stocks that hedge funds have their hands on during the third quarter according to PragCap. They compiled a list of the top 10 stocks among hedge funds a month back and tracked these 3 down to be among the best. There were a total of 103 hedge funds who held stock with Apple, 91 with Microsoft, and 83 with Google who had a total of $5.6 Billion invested with them at the end of June.

Next up, we have Gilead Sciences GILD, a biotech stock which has been sky rocking in the stock market in the past year, soaring over many other biotech stocks. Up 7.02% this year, they are surpassing many stocks and have become one of the most sought after biotech stocks.

Lastly, are we are going to take a look at one of my favorite stocks to date, The SPDR Gold Trust ETF GLD, which owns gold. In the past 6 months, GLD is up 19.04%, YTD adjusts at 30.95%. In the past 2 years, gold has really taken off, currently trading at 171.51 a share, GLD is down 1.07% as of Nov 16, 4PM EST. Take a look at the chart to get a better view of exactly what’s going on with The SPDR Gold Trust ETF GLD.



Top 7 Dividend Stocks to Own

Here are the best sought Dividend stocks. Notice how these stocks are highly volatile but their returns are incredible. ARLP has an overwhelmingly 65% debt to equity percentage but a yield of 6.2%. It is not hard to see the potential returns percentile bellow 50%. Not the highest compound annual growth rate in the bunch neither. A very very VERY risky investment.

Company

Current Yield

Payout Ratio

Debt to Equity

Five-Year Dividend CAGR

ExxonMobil (NYSE: XOM  )2.8%33%15%9%
Illinois Tool Works (NYSE: ITW  )3.0%41%35%17%
The Home Depot (NYSE: HD  )3.3%54%50%20%
Aflac (NYSE: AFL  )2.2%29%27%22%
Walgreen (NYSE: WAG  )2.5%25%27%21%
Owens & Minor (NYSE: OMI  )2.5%33%26%16%
Alliance Resource Partners (Nasdaq:ARLP  )6.2%50%65%16%

ExxonMobil however, proves to be a more passive investment out of the rest, with a 2.8% yield and a payout ratio of 33%. A 15% debt to equity makes it soft to swallow while the five-year dividend compound annual growth rate might shake off some bull-ish investors from buying it.



© JourneyToWallStreet